29-N general election in Almería How to vote, the calendar and every result since 1977

Torrecárdenas and the UAL create a platform to research biomarkers

Topics Almería Centro Comercial Torrecárdenas Universidad de Almería

The agreement, for four years and extendable, will allow biological samples to be analyzed with a nuclear magnetic resonance spectrometer.

AlmeríaYa newsroom ·

Un grupo de catorce personas posa de pie ante una pancarta azul con el escudo y el texto Universidad de Almería, junto a banderas.
Photo: Hospital Universitario Torrecárdenas
The Hospital Universitario Torrecárdenas and the University of Almería (UAL) have signed an agreement to create a Joint Research Platform in Precision Clinical Biomarkers. The agreement will have an initial duration of four years and may be extended for up to four more years. The platform will be used to study biological samples such as blood, plasma, serum, urine, cerebrospinal fluid and different types of tissue. Nuclear magnetic resonance (NMR) techniques applied to metabolomics, the discipline that studies the small molecules produced or used by the body, will be used for this. The analysis makes it possible to identify the substances present in the samples and to research their relationship with health status and with different diseases. The main equipment, a latest-generation NMR spectrometer, will be installed at the UAL's Central Research Services. The platform will be at the service of healthcare professionals and researchers and will be able to support projects in oncology, cardiovascular, neurological, metabolic, inflammatory, infectious, endocrine and rare diseases, as well as personalised medicine studies.

An office at the hospital to coordinate the samples

To coordinate its operation, a Joint Platform Office will be created, with physical headquarters at the Hospital Universitario Torrecárdenas. This office will act as a link between the clinical and research teams, channel proposals and coordinate access to, preparation of and management of the samples. The hospital will provide laboratory spaces to handle and prepare them before sending them to the UAL for analysis. The office will work with the Biobank of the Andalusian Public Health System, Almería node, which will support the conservation, custody, traceability and quality control of the samples and their linking to clinical data, in accordance with current regulations. The collaboration aims to facilitate joint biomedical research projects and bring their results closer to clinical practice. The platform will be open to professionals and researchers at provincial, regional and national level. The agreement has been signed by the managing director of the Hospital Universitario Torrecárdenas, Manuel Vida, and the rector of the UAL, José Céspedes. Vida has stated that the agreement represents "one more step in the joint work carried out by the two institutions". Céspedes has stated that the platform will make it possible to "create a new bridge between academic research and real clinical practice".

Shall we let you know what matters?

Phone alerts

Change or remove it in my alerts